{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:33:17Z","timestamp":1768411997179,"version":"3.49.0"},"reference-count":50,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gates Foundation","award":["INV-034554"],"award-info":[{"award-number":["INV-034554"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/21645515.2024.2313872","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T09:29:22Z","timestamp":1707816562000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China"],"prefix":"10.1080","volume":"20","author":[{"given":"Haonan","family":"Zhang","sequence":"first","affiliation":[{"name":"Peking University","place":["Beijing, China"]},{"name":"Peking University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Peking University","place":["Beijing, China"]},{"name":"Johns Hopkins Bloomberg School of Public Health","place":["Baltimore, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Fang","sequence":"additional","affiliation":[{"name":"Peking University","place":["Beijing, China"]},{"name":"Peking University Health Science Center-Chinese Center for Disease Control and Prevention Joint Center for Vaccine Economics, Peking University","place":["Beijing, China"]},{"name":"Peking University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,2,13]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-346-2_1"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441807"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024343"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.062"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1857201"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.01.007"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2071077"},{"issue":"6","key":"e_1_3_6_9_1","first-page":"648","article-title":"Safety of a domestic group A, C, Y, and W135 meningococcal conjugate vaccine among 3-month-old, 6\u201323-month-old, and 2\u20136-year-old children: a phase III clinical trial","volume":"27","author":"Xie Z","year":"2021","unstructured":"Xie Z, Huang H, Zhang W, Gou J, Huang L, Wang X. Safety of a domestic group A, C, Y, and W135 meningococcal conjugate vaccine among 3-month-old, 6\u201323-month-old, and 2\u20136-year-old children: a phase III clinical trial. Chin J Vaccines Immun. 2021;27(6):648\u201354.","journal-title":"Chin J Vaccines Immun"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000148928.10057.86"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2017.158"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.19.1685"},{"issue":"1","key":"e_1_3_6_13_1","first-page":"54","article-title":"Cost-effectiveness and cost-benefit analysis of meningococcal vaccine immunization in Zhejiang Province from 1978 to 2009","volume":"17","author":"Jiang Z","year":"2011","unstructured":"Jiang Z. Cost-effectiveness and cost-benefit analysis of meningococcal vaccine immunization in Zhejiang Province from 1978 to 2009. Chin J Vaccines Immun. 2011;17(1):54\u20138.","journal-title":"Chin J Vaccines Immun"},{"issue":"4","key":"e_1_3_6_14_1","first-page":"369","article-title":"Cost-benefit evaluation of meningococcal polysaccharide vaccination in Guizhou province","volume":"23","author":"Zhang L","year":"2017","unstructured":"Zhang L. Cost-benefit evaluation of meningococcal polysaccharide vaccination in Guizhou province. Chin J Vaccines Immun. 2017;23(4):369\u201374.","journal-title":"Chin J Vaccines Immun"},{"issue":"6","key":"e_1_3_6_15_1","first-page":"1043","article-title":"Cost-effectiveness comparison of different immunization strategies for meningococcal polysaccharide vaccine in Guizhou Province","volume":"48","author":"Zhang L","year":"2021","unstructured":"Zhang L, Jiang F, Guan Q, Wang M, Liu M, Rui L, Cost-effectiveness comparison of different immunization strategies for meningococcal polysaccharide vaccine in Guizhou Province. Mod Prev Med. 2021;48(6):1043\u20135+54.","journal-title":"Mod Prev Med"},{"issue":"13","key":"e_1_3_6_16_1","first-page":"1331","article-title":"Economic evaluations of immunization strategies for meningococcal vaccines: a systematic review","volume":"31","author":"Zhang HN","year":"2022","unstructured":"Zhang HN, Zhang HJ, Lyu Y, Lai X, Feng H, Wang J, Guo J, Fang H. Economic evaluations of immunization strategies for meningococcal vaccines: a systematic review. Chin J New Drugs. 2022;31(13):1331\u20139.","journal-title":"Chin J New Drugs"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.10.072"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00139-5"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90224-7"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1086\/317667"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2193"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.02.025"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.6.11.12849"},{"key":"e_1_3_6_24_1","unstructured":"World Health Organization. WHO guide for standardization of economic evaluations of immunization programmes. 2019."},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.47.1046"},{"issue":"3","key":"e_1_3_6_26_1","first-page":"241","article-title":"Serogroup distribution of meningococcal meningitis in China, 2015\u20132019","volume":"26","author":"Li J","year":"2020","unstructured":"Li J, Wu D, Wen N, Zheng H, Shi W, Xu L, Shao ZJ, Yin ZD, Li YX. Serogroup distribution of meningococcal meningitis in China, 2015\u20132019. Chin J Vaccines Immun. 2020;26(3):241\u20134.","journal-title":"Chin J Vaccines Immun"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70048-7"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1586\/eri.13.42"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.03.041"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30247-X"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.04.008"},{"key":"e_1_3_6_32_1","unstructured":"World Health Organization. Monitoring vaccine wastage at country level: guidelines for programme managers. 2005."},{"key":"e_1_3_6_33_1","volume-title":"Investigation on economic burden of three main bacterial meningitis cases in some areas","author":"Liu W","year":"2016","unstructured":"Liu W. Investigation on economic burden of three main bacterial meningitis cases in some areas. Beijing: Chinese Center for Disease Control and Prevention; 2016."},{"issue":"4","key":"e_1_3_6_34_1","first-page":"224","article-title":"Clinical characteristics and medical costs of diabetics with amputation at central urban hospitals in China","author":"Wang A","year":"2012","unstructured":"Wang A, Xu Z, Ji L. Clinical characteristics and medical costs of diabetics with amputation at central urban hospitals in China. National Med J China. 2012;92(4):224\u20137.","journal-title":"National Med J China"},{"issue":"7","key":"e_1_3_6_35_1","first-page":"582","article-title":"Evaluation progress of socioeconomic burden of diagnosis and treatment of myopia","author":"Yang Y","year":"2019","unstructured":"Yang Y. Evaluation progress of socioeconomic burden of diagnosis and treatment of myopia. Clin J Experiment Ophthalmol. 2019;37(7):582\u20136.","journal-title":"Clin J Experiment Ophthalmol"},{"issue":"3","key":"e_1_3_6_36_1","first-page":"245","article-title":"Lmmunogenicity and persistence of immunity following a booster of group a and group C meningococcal polysaccharide vaccine among children who hadreceived primary vaccination with group a and group C meningococcal polysaccharide conjugate vaccine","volume":"26","author":"Tang J","year":"2020","unstructured":"Tang J, Li Y, Xu L, Chen X, Mao L, Shi W, Lmmunogenicity and persistence of immunity following a booster of group a and group C meningococcal polysaccharide vaccine among children who hadreceived primary vaccination with group a and group C meningococcal polysaccharide conjugate vaccine. Chin J Vaccines Immun. 2020;26(3):245\u20138.","journal-title":"Chin J Vaccines Immun"},{"key":"e_1_3_6_37_1","first-page":"43","article-title":"Parents\u2019 utilities for outcomes of occult bacteremia","volume":"154","author":"Bennett JE","year":"2000","unstructured":"Bennett JE, Sumner W, Downs SM, Jaffe DM. Parents\u2019 utilities for outcomes of occult bacteremia. Arch Pediatr Adolesc Med. 2000;154:43\u20138.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(02)00448-1"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.85.3.327"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199804000-00011"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1086\/322587"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.85.6.843"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00066-4"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.071"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001512"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175721"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.07.008"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1880209"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188595"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.04.101"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.09.004"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2024.2313872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T17:23:02Z","timestamp":1744651382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2024.2313872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,13]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/21645515.2024.2313872"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2024.2313872","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-11-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2313872"}}